Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Director/PDMR Shareholding

22 Jan 2016 15:31

RNS Number : 7785M
First Derivatives PLC
22 January 2016
 

22 January 2016

First Derivatives plc

("FD" or the "Company")

 

Director's Shareholding

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that Seamus Keating, Chairman, has today acquired 10,000 ordinary shares of 0.5 pence per share in the Company ("Ordinary Shares") at a price of 1,550p per share. Following the transaction, Mr. Keating now has an interest in 25,314 Ordinary Shares, representing 0.1% of the Company's issued share capital.

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Sebastian Lawrence

+44 (0)20 7597 4000

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Walbrook PR

Paul Cornelius

Nick Rome

Helen Cresswell

Sam Allen

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSESFIEFMSEDF
Date   Source Headline
1st Sep 20091:24 pmRNSExercise of Options
3rd Aug 20094:40 pmRNSDirector/PDMR Shareholding
22nd Jul 20092:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20095:00 pmRNSPassing of AGM Resolutions
23rd Jun 20097:00 amRNSAGM Statement
20th May 200912:50 pmRNSDividend Declaration
20th May 20097:00 amRNSDirectorate Change
20th May 20097:00 amRNSFinal Results
24th Apr 20094:45 pmRNSDirector Declaration
1st Apr 20097:00 amRNSAcquisition
31st Mar 20093:12 pmRNSTotal Voting Rights
31st Mar 20097:00 amRNSIEX Notice
25th Mar 20092:47 pmRNSIssue of Equity
30th Jan 20094:20 pmRNSTotal Voting Rights
29th Jan 200910:07 amRNSNew Investment - Replacement
29th Jan 20099:00 amRNSFinancial Support from Invest NI
26th Jan 20097:00 amRNSOEM License Agreement
23rd Jan 20093:45 pmRNSDirector/PDMR Shareholding
16th Jan 20097:00 amRNSDirectorate Change
9th Jan 20094:11 pmRNSExercise of Options
23rd Oct 20087:30 amRNSNon Regulatory Announcement
9th Oct 20087:00 amRNSInterim Results
30th Sep 20082:23 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSIssue of Equity
15th Sep 20087:00 amRNSAcquisition
28th Aug 20083:02 pmRNSAnnual Report and Accounts
27th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSIEX Notice
7th Aug 20084:47 pmRNSIssue of Equity
9th Jul 20087:00 amRNSRe Contract
17th Jun 200812:40 pmRNSAGM Statement
14th May 20087:00 amRNSDirectorate Change
14th May 20087:00 amRNSFinal Results
7th May 20084:22 pmRNSNotice of Results
30th Apr 20081:39 pmRNSTotal Voting Rights
29th Feb 20082:41 pmRNSIssue of Equity
28th Feb 20087:00 amRNSTrading Statement
1st Feb 20084:17 pmRNSResult of EGM
30th Nov 200711:33 amRNSTotal Voting Rights
21st Nov 20075:01 pmRNSDirector/PDMR Shareholding
14th Nov 20071:17 pmRNSIssue of Equity
9th Nov 20074:45 pmRNSDirector/PDMR Shareholding
9th Nov 20074:42 pmRNSDirector/PDMR Shareholding
1st Nov 200710:33 amRNSTotal Voting Rights
4th Oct 20075:27 pmRNSInterim Results - Replacement
4th Oct 20077:01 amRNSInterim Results
28th Sep 20073:01 pmRNSChange of Adviser
23rd Aug 20077:00 amRNSTrading Statement
23rd Aug 20077:00 amRNSTrading Statement
17th Aug 20075:01 pmRNSWebsite Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.